Zacks Small Cap Research on MSN
AEMD: Hitting key milestones as company advances clinical study
By M. Marin NASDAQ: AEMD READ THE FULL AEMD RESEARCH REPORT DSMB recommends AEMD progress clinical trial to the final third cohort Aethlon Medical (NASDAQ: AEMD) announced today that the independent ...
In the fast-paced world of small business ownership, taking time to pause and celebrate achievements—big or small—can sometimes feel like a waste of time or not that meaningful. Yet, research from ...
TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 ...
Hosted on MSN
Researchers hit key milestone in quest to deliver next-gen nuclear power — here's what's happening
A brand new French project is moving one step closer to making nuclear power smaller, safer, and more practical for urban living. At the Cadarache research center, Calogena has signed an agreement ...
We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Viatris, Inc. stands second among them. Viatris, Inc. (NASDAQ:VTRS) reported strong Q2 2025 results, generating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results